Medicine

Projects

Projects per year 1975 1989 2002 2005 2008 2009 2010 2011 2012 2013 2014 2015 2016 2017 2018 2019 2020 2025

• 25 Not started
• 100 Active
• 836 Finished

Projects per year

Search results

• Research project

  SMALL INSTRUMENTATION PROGRAM

  Augenlicht, L. H.

  8/1/90 → 7/31/91

  Project: Research project

• Nutritionally Driven Sporadic Intestinal Tumors: Impact on Stem Cells

  Augenlicht, L. H.

  7/5/18 → 5/31/21

  Project: Research project

  • stem cells 100%
  • colorectal neoplasms 60%
  • homeostasis 53%
  • carcinogenesis 53%
  • neoplasms 47%

• Genetic and Dietary Interactions in MMR Deficient Colon Tumorigenesis

  Edelmann, W., Augenlicht, L. H. & Edelmann, W.

  7/5/18 → 5/31/22

  Project: Research project

  • Hereditary Nonpolyposis Colorectal Neoplasms 100%
  • villin 59%
  • Colon 45%
  • Carcinogenesis 36%
  • Stem Cells 34%

• TL-100 ULTRACENTRIFUGE AND ROTORS

  Augenlicht, L. H.

  12/31/89 → 12/31/89

  Project: Research project

• SITE SPECIFICITY OF GASTROINTESTINAL TUMORIGENESIS

  Augenlicht, L. H. & Rose, S. A.

  3/1/01 → 2/28/05

  Project: Research project

  • Sulindac 100%
  • Neoplasms 58%
  • Small Intestine 41%
  • Carcinogenesis 34%
  • Celecoxib 28%

• New York Regional Center for Diabetes Translation Research

  Gonzalez, J., Walker, E. A. & Wylie-Rosett, J.

  National Institute of Diabetes and Digestive and Kidney Diseases

  9/20/16 → 7/31/22

  Project: Research project

  • chronic illness 100%
  • resources 11%
  • health 11%
  • equity 6%
  • study program 5%

• ANTIBODY STRUCTURE IN ADENOVIRUS INFECTION

  Pirofski, L. & Hoshino, Y.

  1/1/90 → 8/31/90

  Project: Research project

• GASTROENTEROLOGY-HEPATOLOGY RESEARCH

  Wolkoff, A. W., Rose, S. A. & Rose, S. A.

  12/31/89 → 5/31/13

  Project: Research project

• CYTOKINES AS REGULATORS OF HEPATIC FIBROSIS

  Czaja, M. J.

  National Institutes of Health

  7/1/87 → 6/30/92

  Project: Research project

  • liver cirrhosis 100%
  • tumor necrosis factors 85%
  • cytokines 66%
  • growth factors 61%
  • collagen 48%

• MODULATION OF ACUTE TOXIC LIVER INJURY

  Czaja, M. J.

  National Institutes of Health

  4/1/92 → 6/30/17

  Project: Research project

  • Liver 100%
  • Hepatocytes 96%
  • Wounds and Injuries 94%
  • hepatocytes 82%
  • Cell Death 80%

• RCT of An Internet Cessation Program Plus Online Social Network for HIV + Smokers

  Shuter, J., Stanton, C. & Shuter, J.

  8/3/15 → 7/31/21

  Project: Research project

  • HIV 100%
  • Smokers 87%
  • Smoke 79%
  • Smoking Cessation 41%
  • Internet-Based Intervention 27%

• Transcriptional regulation of hematopoietic stem cell fate during aging and bone marrow failure

  Will, B.

  9/22/15 → 7/31/20

  Project: Research project

  • Hematopoietic Stem Cells 100%
  • Cytosine 60%
  • Cellular Senescence 55%
  • DNA Methylation 49%
  • Cell Biology 43%

• Exhaled microRNAs leveraged for lung cancer risk assessment

  Spivack, S. D.

  12/8/14 → 11/30/17

  Project: Research project

  • MicroRNAs 100%
  • Lung Neoplasms 56%
  • Case-Control Studies 38%
  • Early Detection of Cancer 33%
  • Area Under Curve 19%

• A trial of Positively Smoke Free group therapy for HIV-infected smokers

  Shuter, J. & Rose, S. A.

  8/1/13 → 7/31/19

  Project: Research project

  • Smoke 100%
  • HIV 63%
  • Smokers 55%
  • Costs and Cost Analysis 24%
  • Tobacco Use Cessation 18%

• HUMAN ANTIBODIES TO CRYPTOCOCCUS NEOFORMANS

  Pirofski, L. & Rose, S. A.

  12/1/93 → 11/30/10

  Project: Research project

  • cryptococcal polysaccharide 100%
  • Cryptococcus neoformans 67%
  • Anti-Idiotypic Antibodies 67%
  • Antibodies 66%
  • Cryptococcosis 52%

• The Rv2623-Rv1747 interaction: regulation of the in vivo fate of M. tuberculosis

  Chan, J.

  1/16/20 → 12/31/21

  Project: Research project

  • phosphatidylinositol mannoside 100%
  • Mycobacterium tuberculosis 86%
  • Cell Wall 26%
  • Tuberculosis 21%
  • Growth 21%

• Risk for Lung Cancer, Asthma, and COPD;Integrating Clinical and Airway Biomarker

  Spivack, S. D.

  7/12/10 → 6/30/16

  Project: Research project

  • Mentors 100%
  • Chronic Obstructive Pulmonary Disease 53%
  • Biomarkers 52%
  • Pulmonary Medicine 51%
  • Lung Neoplasms 47%

• GENE EXPRESSION IN HUMAN COLON CANCER

  Augenlicht, L. H. & Augenlicht, L. H.

  12/31/89 → 6/30/92

  Project: Research project

  • Colonic Neoplasms 100%
  • Biopsy 67%
  • Adenoma 51%
  • Gene Expression 49%
  • Mucous Membrane 44%

• Effect of longevity genomes on the GH/IGF-1 phenotype and disease-free survival

  Milman, S.

  8/1/15 → 4/30/21

  Project: Research project

  • somatomedins 100%
  • genomics 87%
  • somatotropin 82%
  • phenotype 57%
  • gerontology 51%

• The p110 alpha and delta isoforms of PI3 kinase in hematopoiesis and leukemia

  Gritsman, K.

  9/15/10 → 8/31/15

  Project: Research project

  • Phosphatidylinositol 3-Kinases 100%
  • Leukemia 49%
  • Hematopoietic Stem Cells 40%
  • fms-Like Tyrosine Kinase 3 33%
  • Acute Myeloid Leukemia 28%

• Mechanisms of Hypoglycemia Associated Autonomic Failure

  Hawkins, M. A., Gabriely, I., Rose, S. A., Rose, S. A. & Rose, S. A.

  2/1/08 → 3/31/20

  Project: Research project

  • Hypoglycemia 100%
  • Liver Glycogen 21%
  • Insulin 19%
  • Blood Glucose 19%
  • Glucokinase 15%

• TAXOL--MECHANISMS OF ACTION AND RESISTANCE

  Band Horwitz, S., Smith, A., McDaid, H. M., Band Horwitz, S., McDaid, H. M., Band Horwitz, S., McDaid, H. M., McDaid, H. M., Rose, S. A., Rose, S. A., Rose, S. A., Rose, S. A., Rose, S. A. & Band Horwitz, S.

  6/1/98 → 6/30/21

  Project: Research project

  • paclitaxel 100%
  • microtubules 25%
  • tubulin 20%
  • mechanism of action 17%
  • drugs 13%

• Therapeutic targeting of MDS stem cells

  Steidl, U. G. & Verma, A. K.

  8/20/18 → 6/30/22

  Project: Research project

  • Interleukin-8 100%
  • Stem Cells 42%
  • Heterografts 17%
  • Disease Progression 15%
  • Interleukin-8 Receptors 14%

• FATTY ACID MODULATION OF COLON CELL TRANSFORMATION

  Augenlicht, L. H. & Rose, S. A.

  5/10/07 → 4/30/10

  Project: Research project

  • Butyrates 100%
  • MicroRNAs 30%
  • Sulindac 21%
  • Epigenomics 18%
  • Volatile Fatty Acids 18%

• Antibody Protection in Histoplamosis

  Nosanchuk, J. D. & Rose, S. A.

  12/1/04 → 11/30/10

  Project: Research project

  • Histoplasma 100%
  • Fungi 31%
  • Monoclonal Antibodies 26%
  • Histones 24%
  • Antibodies 24%

• Contribution of macrophages in the HSC niche

  Frenette, P. S.

  4/1/21 → 2/28/22

  Project: Research project

  • Macrophages 100%
  • Bone Marrow 78%
  • Hematopoietic Stem Cells 53%
  • Stem Cell Niche 34%
  • Regeneration 22%

• Achieving smoking cessation milestones in opioid treatment patients: a randomized 2 x 2 factorial trial of directly observed and long-term varenicline

  Nahvi, S.

  4/1/17 → 11/30/21

  Project: Research project

  • Smoking Cessation 100%
  • Varenicline 93%
  • Opioid Analgesics 79%
  • Directly Observed Therapy 55%
  • Withholding Treatment 32%

• HIV and Adiposity in Women: Effects on Bone Metabolism

  Sharma, A.

  9/1/12 → 8/31/18

  Project: Research project

  • HIV 100%
  • Bone and Bones 41%
  • Bone Density 37%
  • Fats 36%
  • Bone Marrow 35%

• CASPASES AND MYOCYTE APOPTOSIS IN HEART FAILURE

  Kitsis, R. N. & Rose, S. A.

  9/30/98 → 6/30/08

  Project: Research project

  • Caspases 100%
  • Apoptosis 98%
  • Cardiac Myocytes 80%
  • Heart Failure 72%
  • Muscle Cells 56%

• MECHANISMS OF CARDIOVASCULAR DISEASE

  Leinwand, L. A., Scheuer, J., Ware, J. A., Sibinga, N., Ware, J. A., Sibinga, N. E. S., Kitsis, R. N., Rose, S. A., Rose, S. A. & Rose, S. A.

  12/31/89 → 6/30/15

  Project: Research project

  • Cardiovascular Diseases 100%
  • Training Support 58%
  • Explosions 56%
  • Human Genetics 56%
  • Organized Financing 54%

• ECOG-ACRIN INTEGRATED LEUKEMIA TRANSLATIONAL RESEARCH CENTER

  Levine, R., Melnick, A. M., Melnick, A. M., Paietta, E. M., Rose, S. A., Rose, S. A., Rose, S. A. & Paietta, E. M.

  4/14/14 → 8/31/19

  Project: Research project

  • leukemia 100%
  • tissue banks 14%
  • clinical trials 13%
  • translational medical research 13%
  • genomics 10%

• Ethippian Integrated Malaria Research Training Programs Planning Grant

  Daily, J. P., Harris, C., Rose, S. A. & Rose, S. A.

  7/1/10 → 6/30/12

  Project: Research project

  • Ethiopia 100%
  • training program 59%
  • grant 30%
  • Federal Ministry 25%
  • training opportunities 22%

• GENE CHANGES AND CHEMOTHERAPY FOR COLON CANCER

  Augenlicht, L. H.

  9/10/92 → 7/31/98

  Project: Research project

  • cooperatives 100%
  • protocols 55%
  • adjuvants 34%
  • colorectal neoplasms 26%
  • neoplasms 25%

• CARDIAC GENE TRANSFER--HYPERTENSION RESPONSIVE ELEMENTS

  Kitsis, R. N.

  7/1/92 → 6/30/97

  Project: Research project

  • Hypertension 100%
  • Ventricular Myosins 90%
  • human MYH7 protein 88%
  • Myosin Heavy Chains 78%
  • Genes 53%

• B cell subsets and immunity to cryptococcosis

  Pirofski, L., Rose, S. A. & Rose, S. A.

  4/1/12 → 3/31/18

  Project: Research project

  • Immunoglobulin M 100%
  • Cryptococcus neoformans 89%
  • B-Lymphocytes 65%
  • Cryptococcosis 64%
  • HIV 48%

• Astrocytic Target Mechanisms in Obesity

  Yang, Y.

  8/1/17 → 7/31/21

  Project: Research project

  • Obesity 100%
  • Astrocytes 87%
  • Adenosine 58%
  • Agouti-Related Protein 57%
  • Diet 32%

• Buprenorphine treatment at syringe exchanges to reduce opioid misuse and HIV risk

  Fox, A. D.

  8/1/17 → 2/28/22

  Project: Research project

  • Buprenorphine 100%
  • Opioid Analgesics 48%
  • Needle-Exchange Programs 47%
  • Therapeutics 16%
  • HIV 16%

• Antibody differentially alters Histoplasma extracellular vesicles

  Nosanchuk, J. D.

  2/15/16 → 1/31/19

  Project: Research project

  • Histoplasma 100%
  • Extracellular Vesicles 35%
  • Fungi 27%
  • Antibodies 22%
  • Monoclonal Antibodies 14%

• Buprenorphine Facilitated Access and Supportive Treatment in Former Inmates

  Fox, A. D.

  7/15/12 → 6/30/18

  Project: Research project

  • Buprenorphine 100%
  • Mentors 31%
  • Opioid Analgesics 15%
  • Opioid-Related Disorders 13%
  • Therapeutics 12%

• Antibodies associated with protection against tuberculosis in nonhuman primates

  Achkar, J. M.

  8/18/17 → 7/31/20

  Project: Research project

  • Tuberculosis 100%
  • Infections 30%
  • Primates 19%
  • Antigens 18%
  • Macaca 15%

• GENE INTERACTIONS IN COLON CANCER

  Augenlicht, L. H.

  4/6/99 → 1/31/05

  Project: Research project

  • Thymidylate Synthase 100%
  • myc Genes 19%
  • Messenger RNA 18%
  • Fluorouracil 15%
  • Colonic Neoplasms 14%

• Sensory Controls of Hyperphagia in Obesity

  Schwartz, G. J. & Rose, S. A.

  3/15/04 → 8/31/10

  Project: Research project

  • mouth 100%
  • leptin 89%
  • obesity 67%
  • portion size 66%
  • mice 59%

• NCI ET-CTN with Phase i Emphasis at UPCI

  Chu, E. & Rose, S. A.

  3/25/14 → 2/28/23

  Project: Research project

  • Clinical Trials 100%
  • Drug Development 48%
  • Therapeutics 25%
  • Cytidine Triphosphate 23%
  • Drug Interactions 16%

• B cells and humoral immunity in tuberculosis

  Chan, J., Rose, S. A. & Rose, S. A.

  12/15/11 → 11/30/17

  Project: Research project

  • B-Lymphocytes 100%
  • Mycobacterium tuberculosis 80%
  • Tuberculosis 64%
  • Mycobacterium bovis 28%
  • T-Lymphocytes 22%

• REGULATION OF THE INSULIN RECEPTOR KINASE

  Pessin, J. E., Pessin, J. E., Rose, S. A., Rose, S. A., Kurland, I. J., Pessin, J. E. & Schwartz, G. J.

  12/31/89 → 7/31/21

  Project: Research project

  • Insulin Receptor 100%
  • Protein Kinases 71%
  • Insulin 45%
  • Adenosine Triphosphate 43%
  • Binding Sites 25%

• In vivo function of macrophage in healthy and diseased erythropoiesis

  Frenette, P. S., Rose, S. A. & Rose, S. A.

  9/26/12 → 6/30/17

  Project: Research project

  • Erythropoiesis 100%
  • Bone Marrow 70%
  • Genetic Models 47%
  • Macrophages 45%
  • Polycythemia Vera 27%

• CORE--ANALYTICAL ULTRASTRUCTURE CENTER

  Bases, R., Kadish, A., Wiernik, P., Orr, G., Bloom, B., Shapiro, L., Lilly, F., Chase, J., Atkinson, P., Maio, J., Reid, L., Levine, W., Nathenson, S., Fant, J., Warner, J., Peisach, J., Horwitz, M., Krauter, K., Makman, M., Blumenfeld, O., Schulman, L., Klinger, H., Rajan, T., Wadler, S., Chance, M., Buhl, S., Desai, K., Pollard, J. W., Sparano, J. A., Hurwitz, J., Duran-Reynals, M., Serrano, L., Alderman, M., Shin, S., West, M., Birshstein, B., Marians, K., Eagle, H., Russel, R., Grills, G., Pickering, K., Mahmood, R., Keller, S. M., Herbst, L., Seither, R., Condeelis, J. S., Edelmann, W., Kucherlapati, R., Gupta, R., Depinho, R., Dutcher, J., Diamond, B., Gaertner, D. J., Keller, S. M., Pollard, J. W., Kucherlapati, R., Gupta, R., Depinho, R., Dutcher, J., Diamond, B., Gaertner, D. J., Herbst, L. H., Goel, S., Scharff, M. D., Scharff, M. D., Scharff, M. D., Band Horwitz, S., Rubin, C. S., Schildkraut, C. L., Band Horwitz, S., Rubin, C. S., Schildkraut, C. L., Maitra, U., Satir, B. H., Cannizzaro, L. A., Cannizzaro, L. A., Childs, G. J., Childs, G. J., Skoultchi, A. I., Rohan, T. E., Porcelli, S. A., Montagna, C., Keller, S. M., Greally, J. M., Stanley, P., Beck, A. P., Steidl, U. G., Strickler, H., Rapkin, B. D. & Sparano, J. A.

  1/1/01 → 6/30/22

  Project: Research project

  • neoplasms 100%
  • species recruitment 77%
  • epidemiology 61%
  • funding 48%
  • histopathology 47%

• Molecular Epidemiology of ARDS and Septic Shock

  Gong, M. N.

  7/1/01 → 5/31/07

  Project: Research project

  • Adult Respiratory Distress Syndrome 100%
  • Septic Shock 70%
  • Plasminogen Activator Inhibitor 1 34%
  • Interleukin 1 Receptor Antagonist Protein 30%
  • Genetic Predisposition to Disease 30%

• TREAT ECARDS: Translating Evidence into Action: Electronic Clinical Decision Support in ARDS

  Gong, M. N.

  9/1/18 → 6/30/21

  Project: Research project

  • Adult Respiratory Distress Syndrome 100%
  • Clinical Decision Support Systems 28%
  • Practice Guidelines 12%
  • Professional Practice 10%
  • Workflow 9%

• Surrogate Consent in Research

  Gong, M. N. & Rose, S. A.

  8/4/06 → 6/30/12

  Project: Research project

  • Research Ethics Committees 100%
  • Genetic Testing 48%
  • Critical Care 41%
  • Risk Assessment 39%
  • Odds Ratio 20%